Viral Latency, Molecular Pathogenesis and Malignancy

Authors

  • Giulio Tarro

latency, herpesvirus, oncogenic viruses, T antigens, papillomavirus

Abstract

Viruses are a major component of the biosphere, entering cells and genomes to insert their own genetic material. Herpesvirus lies hidden for years in the cells of the nervous system before emerging to cause herpes vesicles at the body surface. In the 'virosphere' there are the retroviruses, whose RNA genome can be converted to DNA by the reverse transcriptase enzyme carried in their viral particles, integrating their genes into the host cell genome and becoming one with it. When, for any of a number of reasons, the host immune system undergoes degrees of immunosoppression, the virus can reactivate, replicate, and cause disease. Even when this does not occur, oncogenic virus latency can induce malignancy in host cells.

How to Cite

Viral Latency, Molecular Pathogenesis and Malignancy. (2014). Global Journal of Science Frontier Research, 14(30), 55-60. https://journalofscience.org/index.php/GJSFR/article/view/

References

A. Baldwin, K. Munger (2010) Molecular events associated with human papillomavirus-induced human cancers in Viral Oncology Khalili K., Jeang K-T. (Eds). 23-55.

N. Baranova, M. Carbone (2010) Simian virus 40 and mesothelioma in Viral Oncology Khalili K., Jeang KT. (Eds). 191-209.

T. Block, A. Mehta (2010) Molecular immunobiology of hepatitis B-associated viral cancer in Viral Oncology Khalili K., Jeang K-T. (Eds). 211-224.

Boland RC, Ricciardiello L, Goel A (2010) Involvement of the polyomavirus, JC virus, in colorectal cancer in Viral Oncology Khalili K., Jeang K-T. (Eds). 113-128.

Robert Bowles, John Blaho (2011) A truncation mutation of the neurovirulence ICP22 protein produced by a recombinant HSV-1 generated by bacterial artificial chromosome technology targets infected cell nuclei. 17(6), 559-569. https://doi.org/10.1007/s13365-011-0064-z

J. Butel (2010) Simian virus 40, human infections, and cancer: emerging concepts and causality considerations in Viral Oncology Khalili K., Jeang KT. (Eds). 165-189.

Chen Chang M-H (2010) Hepatitis B vaccine and hepatocellular carcinoma in Viral Oncology Khalili K., Jeang K-T. (Eds). 225-242.

Chen JJ, Gershon AA, Li Z, cowls RA, Gershon MD (2011) Varicella zoster virus (VZV) infects and established latency in enteric neurons. 17(6), 578-589. https://doi.org/10.1007/s13365-011-0070-1

Chowell G, Bertozzi SM, Colchero MA (2009) Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza. 361(7), 674-679. https://doi.org/10.1056/nejmoa0904023

(2012) Emerging role of cytomegalovirus in malignant glioma. 2.

Randall Cohrs, Don Gilden (2012) Alphaherpesvirus latency. 17(6), 509-511. https://doi.org/10.1007/s13365-011-0075-9

W. Dar, B. Sugden (2010) Epstein-Barr virus as a pathogen. 425-451.

F. Dawood, S. Jain, L. Finelli (2009) Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans. 360, 2605-2615.

G. De Falco, C. Bellan, S. Lazzi, L. Leoncini (2010) HIV-related lymphoma in Viral Oncology Khalili K., Jeang K-T. (Eds). 337-349.

L. Ellis, X. Dang, Norton Koralnik (2012) Role of agnogene deletion and archetype-like regulatory region in a JCV strain isolated from the brain of a patient with JCV encephalopathy (JCVE). Presented at: 11th International symposium on Neurovirology. New York, NY. 1, 69.

Martin Enserink, Jon Cohen (2009) Virus of the year. The novel H1N1 influenza. 326(5960), 1607-1607. https://doi.org/10.1126/science.326.5960.1607

Esposito C, Di A, Cuomo N (2012) Tracking the 2009 H1N1 influenza virus in the Italian region Campania. 227(7), 2813-2817. https://doi.org/10.1002/jcp.23030

Feitelson MA, Reis H, Pan J, Sun B (2010) Pathogenesis of acute abd chronic hepatitis C virus infection in Viral Oncology Khalili K., Jeang K-T. (Eds). 243-266.

Finn OJ (2008) Cancer Immunology. 358, 2704-2715.

G. Hayward, J. Donald, R. Arav-Boger (2010) The role of KSHV in pathogenesis of Kaposi's sarcoma in Viral Oncology Khalili K., Jeang K-T. (Eds). 377-407.

Kathrin Held, Tobias Derfuss (2012) Control of HSV-1 latency in human trigeminal ganglia-current overview. 17(6), 518-527. https://doi.org/10.1007/s13365-011-0063-0

M. Imperiale, D. Das (2010) Possible association of BK virus with prostate cancer in Viral Oncology Khalili K. 129-148.

Indovina P, Marcelli E, Pentimalli F, Targenelli P, Tarro G, Giordano A (2012) Mass spectrometry‐based proteomics: The road to lung cancer biomarker discovery. 32(2), 129-142. https://doi.org/10.1002/mas.21355

Paola Indovina, Eleonora Marcelli, Pasquale Maranta, Giulio Tarro (2011) Lung Cancer Proteomics: Recent Advances in Biomarker Discovery. 2011, 1-7. https://doi.org/10.1155/2011/726869

R. Katrenellenbogen, D. Galloway (2010) Human papillomavirus-associated cancers in Viral Oncology Khalili K., Jeang K-T. (Eds). 1-21.

Paul Kinchington, William Goins (2011) Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models. 17(6), 590-599. https://doi.org/10.1007/s13365-011-0069-7

Lister P, Reynolds F, Parslow R (2009) Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. 374, 5-7.

S. Marriott (2010) Oncogenic potential of the HTLV- 1 tax protein in Viral Oncology Khalili K., Jeang K-T. (Eds). 279-293.

M. Matsuoka (2010) Clinical aspects of HTLV-1- associated cancer in Viral Oncology Khalili K., Jeang K-T. (Eds). 279-293.

V. Minhas, C. Wood (2010) Biology and epidemiology of HHV-8 in Viral Oncology Khalili K., Jeang K-T. (Eds). 351-375.

Morens DM, Taubenberger JK, Fauci AS (2009) The Persistent Legacy of the 1918 Influenza Virus. 361, 225-229.

J. Pagano (2010) Molecular pathobiology of EBV infection in Viral Oncology Khalili K., Jeang K-T. (Eds). 409-423.

Perez S (2010) A new era in anticancer peptide vaccines. 116(9). https://doi.org/10.1002/cncr.24988

A. Rathi, J. Pipas (2010) Oncogenic transformation by polyomavirus large T antigen in Viral Oncology Khalili K., Jeang K-T. (Eds). 149-164.

K. Reiss, K. Khalili, Del Valle, L. (2010) JC virus association with brain tumors: the role of T antigen and insulin-like growth factor 1 in DNA repair fidelity in Viral Oncology Khalili K. 89-111.

Bernard Roizman, Guoying Zhou, Te Du (2012) Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues. 17(6), 512-517. https://doi.org/10.1007/s13365-011-0058-x

Nancy Sawtell, Steven Triezenberg, Richard Thompson (2011) VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo. 17(6), 546-551. https://doi.org/10.1007/s13365-011-0065-y

L. Schiller (2008) Noninvasive Monitoring of Tumors. 359(4), 418-420. https://doi.org/10.1056/nejme0804521

Sir D, Ou J (2010) Molecular Mechanisms of hepatitis C virus-induced cellular transformation in Viral Oncology Khalili K., Jeang K-T. (Eds). 267-277.

Gray Stix (2007) A Malignant Flame. 297(1), 60-67. https://doi.org/10.1038/scientificamerican0707-60

St, A. Leger, R. Hendricks (2012) CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation. 17, 528-534.

Giulio Tarro (2009) Tumor liberated protein from lung cancer and perspectives for immunotherapy. 221(1), 26-30. https://doi.org/10.1002/jcp.21851

G. Tarro, C. Esposito (2011) Emerging viral agents at risk in global health approaches to early diagnosis and prompt therapy. 18-21.

Giulio Tarro, Antonio Perna, Ciro Esposito (2005) Early diagnosis of lung cancer by detection of tumor liberated protein. 203(1), 1-5. https://doi.org/10.1002/jcp.20195

M. Thomas, D. Pim, L. Banks (2010) The role of the human papillomavirus E6 oncoprotein in malignant progression in Viral Oncology Khalili K., Jeang K-T. (Eds). 57-58.

Richard Thompson, Nancy Sawtell (2011) The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections. 17(6), 552-558. https://doi.org/10.1007/s13365-011-0071-0

Vergati M (2010) Strategies for Cancer Vaccine Development. 2010, 1-13. https://doi.org/10.1155/2010/596432

Leigh Zerboni, Ann Arvin (2011) Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts. 17(6), 570-577. https://doi.org/10.1007/s13365-011-0066-x

Zimmer SM, Burke DS (2009) Historical Perspective - Emergence of Influenza A (H1N1) Viruses. 361, 279-285.

Zur Hausen, H. (2007) Infections causing human cancer. 532.

Viral Latency, Molecular  Pathogenesis and Malignancy

Published

2014-08-04

How to Cite

Viral Latency, Molecular Pathogenesis and Malignancy. (2014). Global Journal of Science Frontier Research, 14(30), 55-60. https://journalofscience.org/index.php/GJSFR/article/view/